Pure Global
NCT06139692

Comparison of Perioperative Conscious Sedation During Endovascular Thrombectomy in Acute Ischemic Stroke

Comparison of Perioperative Conscious Sedation During Endovascular Thrombectomy in Acute Ischemic Stroke (PEACE) A Randomised Multicentre Trial
Jinling Hospital, China·Phase 4·ClinicalTrials.gov·drugRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Acute Ischemic Stroke
Drug/Device/Intervention
Dexmedetomidine
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Jinling Hospital, China
Location
Nanjing,Chengdu, China
Timeline & enrollment
Phase
Phase 4
Start date
Nov 21, 2023
End date
Feb 13, 2026
Enrollment
810 participants
Primary outcome

The proportion of mRS score 0-2 at 90 days

Summary

This study aims to conduct a multicenter, prospective, randomized clinical trial to
 scientifically evaluate the safety and efficacy of different perioperative sedation methods
 during endovascular thrombectomy in acute ischemic stroke patients with large vessel
 occlusion in the anterior circulation.

ICD-10 classifications
Stroke, not specified as haemorrhage or infarctionSequelae of stroke, not specified as haemorrhage or infarctionCerebral infarctionCerebral infarction, unspecifiedTransient cerebral ischaemic attack, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06139692
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06139692 through Pure Global AI's free database. This Phase 4 trial is sponsored by Jinling Hospital, China and is currently Recruiting. The study focuses on Acute Ischemic Stroke. Target enrollment is 810 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.